当前位置: 首页 > 详情页

PTEN/PI3K/Akt pathway is involved is involved in the protection of hydrogen sulfide against myocardium ischemic/reperfusion injury

| 认领 | 导出 |

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China; [2]Capital Med Univ, Beijing Anzhen Hosp, Intens Care Unit, Dept Cardiol, 2 Anzhen Rd, Beijing 100029, Peoples R China
出处:
ISSN:

关键词: Myocardium ischemic/reperfusion injury hydrogen sulfide phosphatase and tensin homologue PI3K/Akt pathway

摘要:
Myocardial ischemia-reperfusion injury (MIRI) is one of the important reasons for the high mortality of ischemic heart disease in patients who have undergone a blood supply reconstruction. Hydrogen sulfide (H2S) has been thought of to be just a toxic gas with a strong odor of rotten eggs for hundreds of years, but it has been demonstrated that H2S plays a protective role in the pathogenesis and development of heart diseases, especially in MIRI. In the present study, we treated rats with H2S after MIRI and then observed its effects on heart function parameters following in situ ischemia/reperfusion. Multiple oxidative products, myeloperoxidase and proinflammatory cytokines in the myocardium were measured to evaluate the anti-oxidative and anti-inflammatory effect of H2S. The role of phosphatase and tensin homologue (PTEN)/PI3K/Akt pathway was examined to explore the underlying mechanism. The treatment of H2S for seven consecutive days exhibited dramatic improvement in cardiac function, as manifested by increased LVSP and +/- (dP/dt) max, and decreased LVDP. PTEN mRNA and expression were decreased by H2S. PI3K/Akt pathway was activated by H2S and PTEN inhibitor bisperoxovanadium (Phen) but de-activated by PI3K inhibitor LY294002. The heart function was enhanced by Phen but worsened by LY294002, suggesting the involvement of PTEN/PI3K/Akt pathway. These results revealed that H2S may exert its cardioprotection by inactivation of PTEN, which in turn activates the PI3K/Akt signaling and increases survival in the MIRI model.

语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验
最新[2023]版:
JCR分区:
出版当年[2015]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China;
通讯作者:
通讯机构: [2]Capital Med Univ, Beijing Anzhen Hosp, Intens Care Unit, Dept Cardiol, 2 Anzhen Rd, Beijing 100029, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院